Fukushima M, Fukutomi T, Tanabe Y, Hiroshige K, Yoshida K
Dept. of Internal Medicine, Fukuoka City Hospital, Japan.
Gan To Kagaku Ryoho. 1996 Jul;23(8):1073-6.
A 62-year-old man was admitted to our hospital for treatment of HCC with a thrombus growing from the right branch to the trunk of the portal vein. His hepatic functional reserve was fairly good. Serum levels of AFP and PIVKA-II were elevated to 1,780 ng/ml and 27 AU-ml, respectively. The hepatic arteriogram showed a hypervascular tumor approximately 4 cm in diameter in the right anterior segment and many ill-defined small tumor stains around the main tumor. Portal phase of superior mesenteric arteriogram revealed filling defect in the portal trunk, and no visualization of the right branch of portal vein. SMANCS-Lipiodol was infused via right hepatic artery, and Spongel was infused via right anterior branch of hepatic artery. Three months after the first therapy, the tumor markers normalized. A computed tomography scan showed that the main tumor and the tumor thrombus were markedly decreased in size, whereas the hepatic angiogram revealed tumor stains around the main tumor. SMANCS-Lipiodol was again infused via proper hepatic artery. He has remained well for 16 months after the first treatment. The combination of the arterial infusion of SMANCS-Lipiodol with the selective TAE was very effective for this case, probably because his hepatic functional reserve was fairly good and the left branch of portal vein was patent. It was suggested that SMANCS-Lipiodol with the selective TAE could be one therapy to be considered for a patient like this case.
一名62岁男性因门静脉右支至主干生长血栓的肝癌入院治疗。其肝功能储备相当良好。血清甲胎蛋白(AFP)和异常凝血酶原(PIVKA-II)水平分别升高至1780 ng/ml和27 AU/ml。肝动脉造影显示右前叶有一个直径约4 cm的高血运肿瘤,主肿瘤周围有许多边界不清的小肿瘤染色区。肠系膜上动脉造影门静脉期显示门静脉主干充盈缺损,门静脉右支未显影。经右肝动脉注入丝裂霉素-超液化碘油乳剂(SMANCS-Lipiodol),经肝动脉右前支注入明胶海绵(Spongel)。首次治疗三个月后,肿瘤标志物恢复正常。计算机断层扫描显示主肿瘤和肿瘤血栓大小明显减小,而肝血管造影显示主肿瘤周围有肿瘤染色区。再次经肝固有动脉注入SMANCS-Lipiodol。首次治疗后他已健康存活16个月。SMANCS-Lipiodol动脉灌注联合选择性经动脉化疗栓塞术(TAE)对该病例非常有效,可能是因为其肝功能储备相当良好且门静脉左支通畅。提示对于此类患者,SMANCS-Lipiodol联合选择性TAE可作为一种可供考虑的治疗方法。